Category: business

business

Analysis, BioTech, business, Earnings, Finance

Notable Analyst Actions: MWE, ECA, STT, WPC, RTN

Markwest Energy Partners LP (NYSE:MWE) has been downgraded by analysts at Wells Fargo to a Market Perform rating form Outperform. The firm lowered its price target range on the stock to $66-$70 from $70-$74. In the pre-market session, shares of MWE are down 1.12% to $66.50, and move within a 52-week range of $54.60 – $75.79. North American energy producer Encana Corporation (NYSE:ECA, ECA.TO) says … Continue reading Notable Analyst Actions: MWE, ECA, STT, WPC, RTN

Colin Pettis
BioTech, business, Earnings, Energy, Finance

Afternoon Investor Alert: IRM, POM, IG

Records management services provider Iron Mountain Incorporated (NYSE:IRM) reports Q4 2013 adjusted EPS of $0.15 on revenues of $769 million. Analysts had expected adjusted EPS of $0.22 and revenues of $775 million, according to Capital IQ. Year-ago adjusted EPS was $0.20 on revenues of $758 million. For 2014, the company reiterated its adjusted EPS and revenue targets. It said adjusted EPS should be in the … Continue reading Afternoon Investor Alert: IRM, POM, IG

Mark DeFrance
BioTech, business, Earnings, Energy, Finance

Financials in the News: TD, FIG, UNGS, WPX

Financial shares were lower in pre-market session Thursday ahead of durable goods orders data, which is expected to show a slowdown. In financial stocks news, Toronto-Dominion (NYSE:TD, TD.TO) was up about 4% pre-market after it reported adjusted Q1 earnings per share were C$1.06, compared with C$1.00 a year prior. The Street expected earnings of C$1.05 per share, according to Capital IQ estimates. The bank reported … Continue reading Financials in the News: TD, FIG, UNGS, WPX

Mark Doerr
Analysis, BioTech, business, Earnings, Finance

Earnings on Tap After-Market – Valeant Pharmaceuticals International (NYSE:VRX), Sotheby’s Holdings Inc (NYSE: BID)

Valeant Pharmaceuticals International (NYSE:VRX) is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect light trading in the issue immediately following its quarterly earnings announcement. Historical earnings event related premarket and after-hours trading activity in VRX indicates that the price change in the extended hours is likely to be of limited value in forecasting additional price … Continue reading Earnings on Tap After-Market – Valeant Pharmaceuticals International (NYSE:VRX), Sotheby’s Holdings Inc (NYSE: BID)

Richard Atkins
BioTech, business, Finance, Financial, misc, news

Earnings Watch: HII, WEN, RBS, IRM, KBR, NRG

Huntington Ingalls Industries (NYSE:HII) reported Q4 earnings that were well ahead of analysts’ estimates. The ship- and submarine builder said its adjusted diluted earnings rose nearly 28% to $1.66, exceeding the $1.22 average estimate from analysts polled by Capital IQ, if comparable. On a non-adjusted basis, diluted net earnings rose to $91 million from $50 million. Sales in the quarter meanwhile rose 6.2% to $1.94 … Continue reading Earnings Watch: HII, WEN, RBS, IRM, KBR, NRG

John Meady
Analysis, BioTech, business, Earnings

Aegerion Pharmaceuticals (NASDAQ:AEGR) Curbs Losses in Quarter

Aegerion Pharmaceuticals (NASDAQ:AEGR) is lower after it reported a Q4 loss that was smaller than analysts had expected and set a FY14 sales guidance that straddled estimates. Shares are down 11.48% at $58.73 with a 52-week range of $28.33 – $101.00. In the quarter, the biopharmaceutical company had a non-GAAP loss of $0.14 per share, down from a loss of $0.71 the year earlier and … Continue reading Aegerion Pharmaceuticals (NASDAQ:AEGR) Curbs Losses in Quarter

Ryan Holtz